backgrounda
high
incid
nontraumat
osteonecrosi
report
hivinfect
patient
investig
level
ddimer
creactiv
protein
crp
cohort
hivinfect
adult
without
osteonecrosi
femor
head
hivinfect
patient
osteonecrosi
femor
head
comparison
group
hivinfect
patient
neg
mr
imag
hip
serial
plasma
sampl
avail
includ
ddimer
crp
level
measur
prior
time
diagnosi
osteonecrosi
patient
time
neg
mr
imag
hip
control
month
later
group
resultsbiomark
level
elev
time
diagnosi
osteonecrosi
cohort
compar
control
median
ddimer
valu
osteonecrosi
group
compar
control
group
crp
correspond
valu
mgl
mgl
postdiagnosi
ddimer
crp
level
also
elev
osteonecrosi
patient
compar
control
linear
regress
demonstr
rise
ddimer
level
prediagnosi
diagnosi
osteonecrosi
patient
crp
level
chang
significantli
time
conclusionscompar
control
patient
develop
osteonecrosi
elev
level
ddimer
crp
diagnosi
ddimer
level
increas
crp
level
chang
significantli
prediagnosi
diagnosi
data
suggest
patient
higher
level
inflamm
increas
risk
osteonecrosi
hiv
osteonecrosi
ddimer
creactiv
protein
background
high
incid
nontraumat
osteonecrosi
report
hivinfect
patient
although
case
frequent
associ
wellestablish
predispos
factor
osteonecrosi
includ
corticosteroid
use
hyperlipidemia
alcohol
abus
studi
also
identifi
proteas
inhibitor
use
histori
advanc
hiv
diseas
risk
factor
popul
pathogenesi
well
understood
postul
nontraumat
osteonecrosi
develop
result
intravascular
coagul
follow
increas
intraosseu
venou
pressur
reduc
arteri
flow
hypox
bone
death
support
procoagul
abnorm
inherit
acquir
associ
increas
risk
osteonecrosi
group
previous
identifi
associ
posit
anticardiolipin
antibodi
osteonecrosi
hivinfect
adult
differ
seen
lupu
anticoagul
protein
level
cohort
compar
hivinfect
control
without
osteonecrosi
hivinfect
patient
elev
level
ddimer
fibrin
degrad
product
recent
associ
increas
risk
death
opportunist
infect
level
creactiv
protein
crp
acut
phase
protein
proinflammatori
antiinflammatori
effect
elev
hivinfect
adult
rel
hiv
neg
control
crp
level
correl
hiv
diseas
progress
independ
tcell
count
hiv
viral
load
predict
surviv
hivinfect
individu
popul
elev
crp
level
associ
tradit
cardiovascular
diseas
risk
factor
includ
tobacco
use
elev
cholesterol
well
increas
viscer
adipos
tissu
lipodystrophi
clinic
implic
elev
crp
optim
util
crp
level
evalu
hiv
infect
adult
yet
establish
larger
clinic
trial
howev
sinc
coagul
inflamm
thought
play
role
develop
osteonecrosi
investig
level
ddimer
crp
longitudin
sampl
wellcharacter
cohort
hivinfect
adult
without
osteonecrosi
femor
head
hivinfect
patient
either
asymptomat
symptomat
osteonecrosi
femor
head
enrol
studi
nih
clinic
center
serial
plasma
sampl
avail
includ
studi
asymptomat
patient
identifi
mri
scan
perform
part
previous
report
prospect
studi
symptomat
patient
mri
confirm
enrol
natur
histori
studi
osteonecrosi
fifti
hivinfect
patient
evid
osteonecrosi
mri
scan
perform
part
studi
serial
plasma
sampl
avail
serv
control
group
latter
group
previous
serv
control
group
analysi
coagul
abnorm
associ
osteonecrosi
note
clinic
laboratori
data
previous
publish
report
preval
incid
natur
histori
osteonecrosi
hivinfect
patient
concentr
ddimer
plasma
sampl
frozen
measur
use
sta
liatest
ddi
immunoturbidimetr
assay
diagnostica
stago
detect
limit
level
crp
determin
highli
sensit
immunonephelometri
test
hscrp
bnii
siemen
healthcar
diagnost
detect
limit
mgl
osteonecrosi
cohort
sampl
select
time
osteonecrosi
diagnosi
month
timepoint
least
month
prior
least
month
diagnosi
time
point
control
particip
sampl
select
time
neg
mri
imag
month
later
valu
detect
limit
assay
assign
valu
ddimer
mgl
crp
primari
object
compar
ddimer
crp
level
patient
osteonecrosi
control
look
associ
biomark
level
osteonecrosi
ddimer
crp
level
compar
time
mri
scan
diagnosi
osteonecrosi
document
normal
femor
head
control
patient
osteonecrosi
control
use
mannwhitney
ustatist
evalu
relationship
biomark
level
time
osteonecrosi
line
fit
subject
biomark
valu
time
slope
line
describ
chang
time
compar
osteonecrot
patient
control
use
mann
whitney
ustatist
well
linear
regress
model
adjust
viral
load
total
count
store
plasma
sampl
avail
osteonecrosi
patient
asymptomat
symptomat
diseas
sampl
avail
timepoint
prior
diagnosi
osteonecrosi
patient
median
month
rang
month
time
diagnosi
patient
median
month
time
diagnosi
rang
month
diagnosi
patient
median
month
rang
month
control
patient
sampl
avail
time
neg
mri
imag
month
later
median
month
demograph
characterist
patient
includ
studi
similar
total
cohort
publish
previous
select
demograph
clinic
paramet
particip
time
mri
imag
summar
tabl
osteonecrosi
cohort
differ
control
known
durat
hiv
infect
year
vs
year
tcell
count
vs
signific
differ
seen
percentag
patient
receiv
antiretrovir
therapi
osteonecrosi
cohort
vs
control
percentag
patient
suppress
viral
load
osteonecrosi
cohort
vs
control
antiretrovir
regimen
similar
two
group
reflect
clinic
popul
time
osteonecrosi
patient
control
receiv
prior
therapi
note
control
patient
receiv
year
preced
sampl
timepoint
interv
rang
day
six
osteonecrosi
patient
receiv
proxim
sampl
timepoint
rang
day
previous
report
osteonecrosi
patient
higher
frequenc
anticardiolipin
igg
antibodi
level
greater
unit
vs
ddimer
crp
level
significantli
elev
time
diagnosi
osteonecrosi
cohort
compar
control
tabl
ddimer
median
valu
osteonecrosi
group
compar
control
group
crp
correspond
valu
mgl
mgl
ddimer
crp
level
also
significantli
elev
osteonecrosi
patient
compar
control
postdiagnosi
period
figur
relationship
remain
signific
adjust
made
hiv
viral
load
anticardiolipin
antibodi
statu
examin
chang
ddimer
crp
time
group
signific
differ
observ
linear
regress
use
data
osteonecrosi
patient
sampl
avail
least
two
time
point
n
control
patient
time
point
adjust
hiv
viral
load
first
timepoint
demonstr
ddimer
level
rose
prediagnosi
diagnosi
osteonecrosi
patient
remain
stabl
control
cohort
crp
level
stabl
time
slope
differ
zero
osteonecrosi
control
cohort
differ
seen
ddimer
crp
level
asymptomat
symptomat
cohort
data
shown
studi
demonstr
occurr
osteonecrosi
hivinfect
patient
associ
increas
level
two
biomark
associ
poor
clinic
outcom
hivinfect
patient
compar
control
patient
develop
osteonecrosi
elev
level
ddimer
crp
diagnosi
osteonecrosi
patient
sampl
avail
prior
diagnosi
ddimer
level
increas
crp
remain
unchang
time
wherea
signific
chang
note
either
biomark
control
cohort
data
suggest
elev
ddimer
associ
develop
osteonecrosi
crp
elev
howev
predat
develop
osteonecrosi
suggest
atrisk
patient
persist
higher
level
chronic
inflamm
potenti
result
ongo
immun
activ
compar
control
cohort
hivinfect
patient
develop
osteonecrosi
often
tradit
risk
factor
associ
develop
osteonecrosi
popul
appear
increas
risk
context
risk
factor
given
find
studi
one
potenti
explan
develop
osteonecrosi
multifactori
chronic
inflamm
evidenc
persist
higher
level
crp
creat
environ
exampl
use
corticosteroid
result
much
greater
risk
develop
osteonecrosi
direct
role
chronic
inflamm
play
develop
osteonecrosi
determin
studi
nontraumat
osteonecrosi
femor
head
patholog
character
venou
hypertens
impair
venou
circul
thought
caus
intravascular
coagul
microcirculatori
thrombosi
result
compromis
venou
drainag
associ
thrombophilia
andor
hypofibrinolysi
osteonecrosi
adult
report
numer
studi
span
year
nilsson
describ
case
osteonecrosi
hip
associ
hypofibrinolysi
subsequ
associ
describ
level
osteonecrosi
depress
fibrinolysi
postul
result
inadequ
lysi
venou
thrombi
bone
impair
bone
venou
circul
venou
hypertens
bone
report
ddimer
crp
level
patient
osteonecrosi
limit
recent
report
evalu
patient
idiopath
corticosteroidassoci
osteonecrosi
ddimer
level
significantli
higher
latter
tend
higher
former
compar
similarli
age
control
group
ddimer
level
also
significantli
higher
gaucher
diseas
patient
osteonecrosi
compar
without
osteonecrosi
crp
level
significantli
elev
cohort
patient
nontraumat
osteonecrosi
compar
ageand
sexmatch
control
howev
report
patient
sever
acut
respiratori
syndrom
sar
subsequ
develop
osteonecrosi
found
osteonecrosi
patient
differ
control
level
protein
c
plasminogen
activ
inhibitor
plasminogen
antithrombin
iii
ddimer
level
studi
sampl
drawn
diagnosi
osteonecrosi
least
month
treatment
sar
osteonecrosi
thu
appear
anoth
complic
hiv
infect
like
cardiovascular
diseas
consequ
ongo
immun
activ
inflamm
whether
immunosuppress
contribut
risk
osteonecrosi
uncertain
median
count
lower
osteonecrosi
group
group
rel
high
median
count
major
patient
group
viral
load
copiesml
biomark
ddimer
crp
potenti
identifi
hivinfect
patient
increas
risk
osteonecrosi
nonopportunist
complic
may
good
candid
assess
therapeut
strategi
focu
reduc
nonopportunist
complic
ddimer
top
panel
crp
bottom
panel
valu
hivinfect
patient
osteonecrosi
control
median
interquartil
rang
present
osteonecrosi
patient
time
point
repres
data
osteonecrosi
diagnosi
month
prior
diagnosi
time
point
diagnosi
month
time
point
diagnosi
month
diagnosi
control
particip
time
point
repres
data
time
neg
mr
imag
hip
time
point
month
later
dash
line
indic
lower
limit
detect
assay
